Bosnia's RWP Vitorog gets energy permit for 110 MW wind farm
Ljubljana share indices decline, Cinkarna Celje paces losers
Sofia bource indices rally on gains in Fibank, Telematic Interactive
Podravka buoys Croatia’s share indices
Foreign visitor overnights in Kosovo rise 28% y/y in Oct
Dec 07, 2009 13:39 EEST
SOFIA (Bulgaria), December 2 (SeeNews) – The November sales of Bulgarian blue-chip drug maker Sopharma were 25% higher than a year ago, the company said.
Domestic sales fell 5.0% from November 2008, while exports rose 41% on the year.
Domestic sales rose 8.0% on the year in the 11 months through November and exports were 11% higher.
Total sales in the first 11 months of 2009 were 10% up from the same period of 2008 and 0.43% higher than the sales for all of 2008. The January-November exports to the Balkan region more than doubled and exports to EU member states rose 21% compared all of 2008.
The company ended last year with a net profit of 19.3 million levs ($14.62 million/9.87 million euro) on sales of 187.5 million levs.
Sopharma (www.sopharma.bg) exports to 28 countries with Russia and other former Soviet republics as its main markets abroad. The company has said it will aim to expand its presence in Russia, Ukraine and Poland, and to enter the U.S. market as well as markets in the Caucasus and in central and eastern Europe.
Sopharma shares were traded 0.51% down at 4.1 levs in a volume of 45,220 stocks by 1030 GMT on Monday on the Sofia stock exchange. On Friday, Sopharma closed 0.96% up at 4.12 levs in a volume of 11, 273 stocks.
(1 euro = 1.95583 Bulgarian levs)
You have run out of free articles this month.
Sign up in for
and get ten (10) free articles per month or sign up for
and get unlimited access.
Browse our free newsletter options